Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Edit custom filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1993 1
2004 1
2008 1
2011 2
2012 2
2013 3
2017 1
2018 1
2021 1
2022 2
2025 2
2026 1

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

18 results

Results by year

Filters applied: Meta-Analysis, Randomized Controlled Trial. Clear all
Page 1
[Compression of nerves and senses: ipidacrine as the light at the end of the tunnel].
Merkulov YA, Magomedova AM, Biglova AN, Gamburg AM, Tashanova BA, Merkulova DM. Merkulov YA, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2021;121(2):31-37. doi: 10.17116/jnevro202112102131. Zh Nevrol Psikhiatr Im S S Korsakova. 2021. PMID: 33728848 Clinical Trial. Russian.
OBJECTIVE: To evaluate the efficacy of the AChE inhibitor ipidacrine when added to traditional therapy in outpatients with tunnel syndromes (TS) based on clinical, neurophysiological and psycho-emotional indicators. MATERIAL AND METHODS: Ninety-two patients with a verified …
OBJECTIVE: To evaluate the efficacy of the AChE inhibitor ipidacrine when added to traditional therapy in outpatients with tunnel syn …
[Pharmacological correction of burning eye syndrome].
Safonova TN, Medvedeva ES. Safonova TN, et al. Vestn Oftalmol. 2025;141(2):51-58. doi: 10.17116/oftalma202514102151. Vestn Oftalmol. 2025. PMID: 40353541 Clinical Trial. Russian.
They were randomly assigned to two groups: group 1 received gabapentin combined with neuroprotective therapy (thioctic acid, ipidacrine, and B vitamins) and topical 0.4% hyaluronic acid (HA) four times daily, while group 2 received only tear substitution therapy with 0.4% …
They were randomly assigned to two groups: group 1 received gabapentin combined with neuroprotective therapy (thioctic acid, ipidacrine …
[Systematic review and meta-analysis of clinical trials of the efficacy and safety of ipidacrine for the treatment of peripheral neuropathies].
Amelin AV, Zhivolupov SA, Suponeva NA, Khramilin VN. Amelin AV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2026;126(2):68-76. doi: 10.17116/jnevro202612602168. Zh Nevrol Psikhiatr Im S S Korsakova. 2026. PMID: 41782533 Russian.
OBJECTIVE: To evaluate the efficacy and safety of adding ipidacrine to the therapy of patients with peripheral neuropathies (PN) of any etiology. ...There was no clinically significant increase in the incidence of adverse events when ipidacrine was added to therapy. …
OBJECTIVE: To evaluate the efficacy and safety of adding ipidacrine to the therapy of patients with peripheral neuropathies (PN) of a …
EFFECTIVENESS OF ALPHA-LIPOIC ACID AND IPIDACRINE HYDROCHLORIDE IN PREVENTION OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY ASSESSED BY ELECTRONEUROMYOGRAPHY OF SUPERFICIAL PERONEAL AND SURAL NERVES.
Holotiuk IS, Kryzhanivska AY, Holotiuk SI, Holotiuk VV, Maliborska SV. Holotiuk IS, et al. Exp Oncol. 2022 Dec;44(4):300-306. doi: 10.32471/exp-oncology.2312-8852.vol-44-no-4.19030. Exp Oncol. 2022. PMID: 36811539 Clinical Trial.
AIM: To investigate the neurofunctional parameters in breast cancer (BC) patients with paclitaxel-induced peripheral neuropathy (PIPN) and to clarify the feasibility of using alpha-lipoic acid (ALA) in combination with the acetylcholinesterase inhibitor ipidacrine hydrochl …
AIM: To investigate the neurofunctional parameters in breast cancer (BC) patients with paclitaxel-induced peripheral neuropathy (PIPN) and t …
EVALUATION OF THE EFFICIENCY OF ALPHA-LIPOIC ACID AND IPIDACRINE HYDROCHLORIDE FOR THE PREVENTION OF PACLITAXEL-INDUCED PERIPHERAL NEUROPATHY ACCORDING TO THE TOTAL NEUROPATHY SCORE.
Holotiuk IS, Kryzhanivska AY, Holotiuk SI, Maliborska SV, Holotiuk VV. Holotiuk IS, et al. Exp Oncol. 2022 May;44(1):75-82. doi: 10.32471/exp-oncology.2312-8852.vol-44-no-1.17257. Exp Oncol. 2022. PMID: 35548968 Clinical Trial.
AIM: To evaluate the efficacy of combination of alpha-lipoic acid and acetylcholinesterase inhibitor (ipidacrine hydrochloride) to prevent the development and improve the course of paclitaxel-induced peripheral neuropathy (PIPN) in patients with breast cancer according to …
AIM: To evaluate the efficacy of combination of alpha-lipoic acid and acetylcholinesterase inhibitor (ipidacrine hydrochloride) to pr …
[An effect of ipidacrine (neuromidin) on electroneuromyographic parameters in the conditions of artificial decompression (a clinical/instrumental study)].
Bahtereva EV, Shirokov VA, Leiderman EL, Terechov NL, Varaksin AN, Panov VG. Bahtereva EV, et al. Zh Nevrol Psikhiatr Im S S Korsakova. 2017;117(1):25-28. doi: 10.17116/jnevro20171171125-28. Zh Nevrol Psikhiatr Im S S Korsakova. 2017. PMID: 28252600 Clinical Trial. Russian.
RESULTS AND CONCLUSION: There was the significant depression of the nerve function and worsening of ENMG parameters during the additional decompression as well as the aggravation of conduction block along nerve fibers (motor and sensory). In patients treated with ipidacrine …
RESULTS AND CONCLUSION: There was the significant depression of the nerve function and worsening of ENMG parameters during the additional de …
Cholinergic medication for antipsychotic-induced tardive dyskinesia.
Tammenmaa-Aho I, Asher R, Soares-Weiser K, Bergman H. Tammenmaa-Aho I, et al. Cochrane Database Syst Rev. 2018 Mar 19;3(3):CD000207. doi: 10.1002/14651858.CD000207.pub2. Cochrane Database Syst Rev. 2018. PMID: 29553158 Free PMC article.
OBJECTIVES: To determine the effects of cholinergic drugs (arecoline, choline, deanol, lecithin, meclofenoxate, physostigmine, RS 86, tacrine, metoxytacrine, galantamine, ipidacrine, donepezil, rivastigmine, eptastigmine, metrifonate, xanomeline, cevimeline) for treating a …
OBJECTIVES: To determine the effects of cholinergic drugs (arecoline, choline, deanol, lecithin, meclofenoxate, physostigmine, RS 86, tacrin …
PREVENTION OF PACLITAXEL-INDUCED MOTOR NEUROPATHY OF FIBULAR AND TIBIAL NERVES WITH ALPHA-LIPOIC ACID AND IPIDACRIN HYDROCHLORIDE IN BREAST CANCER PATIENTS.
Holotiuk I, Kryzhanivska A, Holotiuk S, Teren T, Hirna H. Holotiuk I, et al. Exp Oncol. 2025 Oct 7;47(2):230-237. doi: 10.15407/exp-oncology.2025.02.230. Exp Oncol. 2025. PMID: 41058457 Clinical Trial.
AIM: To investigate neurofunctional parameters of motor nerves in breast cancer (BCa) patients with paclitaxelinduced peripheral neuropathy (PIPN) and to determine the feasibility of using alpha-lipoic acid (ALA) in combination with ipidacrine hydrochloride (IPD) for PIPN …
AIM: To investigate neurofunctional parameters of motor nerves in breast cancer (BCa) patients with paclitaxelinduced peripheral neuropathy …
Systematic review of cholinergic drugs for neuroleptic-induced tardive dyskinesia: a meta-analysis of randomized controlled trials.
Tammenmaa IA, Sailas E, McGrath JJ, Soares-Weiser K, Wahlbeck K. Tammenmaa IA, et al. Prog Neuropsychopharmacol Biol Psychiatry. 2004 Nov;28(7):1099-107. doi: 10.1016/j.pnpbp.2004.05.045. Prog Neuropsychopharmacol Biol Psychiatry. 2004. PMID: 15610922
The authors evaluated the efficacy of cholinergic drugs in the treatment of neuroleptic-induced tardive dyskinesia (TD) by a systematic review of the literature on the following agents: choline, lecithin, physostigmine, tacrine, 7-methoxyacridine, ipidacrine, galantamine, …
The authors evaluated the efficacy of cholinergic drugs in the treatment of neuroleptic-induced tardive dyskinesia (TD) by a systematic revi …
18 results